Ned Pagliarulo@NedPagliarulo Dive Brief: Merck & Co. said Monday it will spend $425 million to acquire OncoImmune, a small Maryland-based biotech company, and its experimental COVID-19 treatment,…
Ned Pagliarulo@NedPagliarulo Dive Brief: Merck & Co. said Monday it will spend $425 million to acquire OncoImmune, a small Maryland-based biotech company, and its experimental COVID-19 treatment,…